Lead Story · Research
The Peptide Boom, From TikTok Bans to Hospitalizations: What This Week’s Headlines Really Mean
By Sean Rakidzich · October 25, 2026
Monday, October 26, 2026 · Independent science journalism
Research
1,180 Emergency Visits Mentioned Peptides. The Hardest Question Is What Was Actually in the Vial.
New Australian hospital surveillance shows a sharp rise in emergency visits involving mentions of unapproved peptides. A separate laborat…
Research
Your Coworker Might Be on BPC-157. He’s Just Not Going to Tell You.
Peptides have become mainstream enough to be discussed by Harvard, debated by the FDA, restricted in TikTok search, and still whispered a…
Recovery
More →Recovery
When the MRI Says “Normal” but Your Knee Still Feels Wrong
A reassuring scan does not always resolve persistent knee symptoms. What that means for recovery—and what the limited human evidence can …
Recovery
A Collagen Dressing Closed More Difficult Diabetic Foot Wounds. The Trial’s Narrow Win Matters.
In a 170-person randomized trial of difficult diabetic foot ulcers, 42% of wounds closed with a collagen-PHMB matrix plus standard care, …
Recovery
An Antioxidant Helped Some Muscles Recover—and Delayed Repair in Others
A 24-man randomized crossover study found NAC helped muscle repair in participants with low muscle glutathione but impaired repair in tho…
Recovery
Cold Plunge or Hot Bath? Start With the Recovery You Actually Need
Soreness, restored strength, tissue repair and muscle growth are different goals. Read hot- and cold-water recovery studies with that dis…
Beauty
More →Beauty
An Experimental Cream Shifted a Skin-Aging Clock. What Actually Changed?
Rubedo reports a lower skin-aging clock score in 11 paired samples after experimental RLS-1496 cream. Clinical rejuvenation remains unpro…
Wellness
More →Wellness
Survodutide Produced Nearly 10% Weight Loss in Adults With Diabetes. The Placebo Group Makes the Result More Interesting.
SYNCHRONIZE-2 studied 752 adults with type 2 diabetes. Survodutide led to 8.2–9.8% weight loss against 3.9% placebo, with high GI-event r…
Wellness
The Missing Chapter in GLP-1 Weight Loss: What Happens After Treatment Stops
What happens when GLP-1 treatment ends? Compare withdrawal trials, exercise follow-up and the limits of evidence about keeping weight off.
Wellness
Why the Peptide Story Is So Persuasive
Analysis: The appeal is not just that these molecules are new. It is that they seem to offer a precise answer to problems people experien…
Wellness
LL-37, Wound Healing and the Limits of the Hantavirus Connection
A human wound-healing program shows both the promise and the difficulty of translating LL-37 biology into treatment. It also shows why an…
Aging
More →Aging
ER-100 and Yamanaka Factors: The Bid to Restore Vision by Reprogramming Cells
The experimental gene therapy borrows tools that can reset a cell’s identity. Its more delicate goal is to recover function without makin…
Aging
A Senolytic Trial Improved Liver Scarring. Thirty-One Participants Are Enough to Ask the Next Question.
An October 2026 randomized trial reported fibrosis improvement with dasatinib plus quercetin in MASH. The biopsy signal is promising but …
Aging
Your Immune System May Have Its Own Aging Trajectory. A New Cell Map Explains Why.
An October 2026 Immunity study compares immune-cell patterns in 2,609 people. Learn why the granzyme K/B ratio is promising but not a cli…
Aging
Bonn’s Cell-Rejuvenation Study Has a Surprising Strength: It Takes Its Time
Why Bonn’s slow blood-to-neural-stem-cell conversion may help aging research, and why a younger molecular clock is not proof of human rej…